Objectives: To describe different sleep disorders and daytime sleepiness in a French population of randomly selected young women during pregnancy and to evaluate the frequency of these sleep disorders according to the three trimesters of pregnancy. Methods: Cross-sectional design with retrospective survey of pre-pregnancy, symptoms and prospective survey of current symptoms. Mothers were interviewed during pregnancy with a questionnaire to evaluate their sleep before pregnancy and to assess alterations in their sleep according to the trimester. Results: 871 pregnant women completed the questionnaire. The rate of pregnant women with insomnia with non-refreshing sleep and frequent awakenings increases during the second and the third trimester reaching more than 75% of the women, essentially due to an urge to urinate, movements of the fetus, backache and restless legs syndrome. Snoring also increases throughout the pregnancy with more than 18% of them snoring every night. Conversely, more than 75% of the women complained of a decrease in their vigilance and a need to nap inreased during the pregnancy. Conclusions: The subjective quality of sleep is disturbed as early as the first trimester of pregnancy and increases throughout the pregnancy, except for excessive daytime sleepiness which was more frequent during the first trimester.

Keywords:
Pregnancy, Sleep disorders, Excessive daytime sleepiness
1.
Lee KA: Alterations in sleep during pregnancy and postpartum: a review of 30 years of research. Sleep Med Rev 1998;2:231–242.
2.
Hedman C, Pohjasvaara T, Tolonen U, et al: Effect of pregnancy on mother’s sleep. Sleep Med 2002;3:37–42.
3.
Moline ML, Borch L, Zak R, et al: Sleep in women across the life cycle from adulthood through menopause. Sleep Med Rev 2003;7:155–177.
4.
Pien GW, Schwab RJ: Sleep disorders during pregnancy. Sleep 2004;27:1405–1417.
5.
Izci B, Martin SE, Dundas KC, et al: Sleep complaints: snoring and daytime sleepiness in pregnant and pre-eclamptic women. Sleep Med 2005;6:163–169.
6.
Brunner DP, Munch M, Biedermann K, et al: Changes in sleep and sleep electroencephalogram during pregnancy. Sleep 1994;17:576–582.
7.
Manconi M, Govoni V, De Vito A, et al: Restless legs syndrome and pregnancy. Neurology 2004;63:1065–1069.
8.
Poyares D, Guilleminault C, Hachul H, et al: Pre-eclampsia and nasal CPAP. 2. Hypertension during pregnancy, chronic snoring, and early nasal CPAP intervention. Sleep Med 2008;9:15–21.
9.
Sahin FK, Koken G, Cosar E: Obstructive sleep apnea in pregnancy and fetal outcome. Int J Gynaecol Obstet 2008;100:141–146.
10.
Johns MW: A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991;14:540–545.
11.
Buysse DJ, Reynols CF III, Monk TH, et al: The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989;28:193–213.
12.
Mindell JA, Jacobson BJ: Sleep disturbances during pregnancy. J Obstet Gynecol Neonatal Nurs 2000;29:590–597.
13.
Lee KA, Gay CL: Sleep in late pregnancy predicts length of labor and type of delivery. Am J Obstet Gynecol 2004;191:2041–2046.
14.
Schweiger MS: Sleep disturbance in pregnancy. A subjective survey. Am J Obstet Gynecol 1972;114:879–882.
15.
Lee KA, Zaffke ME, McEnany G: Parity and sleep patterns during and after pregnancy. Obstet Gynecol 2000;95:14–18.
16.
Hertz G, Fast A, Feinsilver SH, et al: Sleep in normal late pregnancy. Sleep 1992;15:246–251.
17.
McParland P, Pearce JM: Restless legs syndrome in pregnancy. Case reports. Clin Exp Obstet Gynecol 1990;17:5–6.
18.
Baratte-Beebe KR, Lee KA: Sources of midsleep awakenings in childbearing women. Clin Nurs Res 1999;8:386–397.
19.
Suzuki S, Dennerstein L, Greenwood KM, et al: Sleeping patterns during pregnancy in Japanese women. J Psychosom Obstet Gynaecol 1994;15:19–26.
20.
Guerreiro Da Silva JB, Nakamura MU, Cordeiro JA, et al: Acupuncture for insomnia in pregnancy. Acupunct Med 2005;23:47–51.
21.
Damase-Michel C, Vié C, Lacroix I, et al: Drug counselling in pregnancy: an opinion survey of French community pharmacists. Phamocoepidemiol Drug Saf 2004;13:1–5.
22.
Loube DI, Poceta JS, Morales MC, et al: Self-reported snoring in pregnancy association with fetal outcome. Chest 1996;109:885–889.
23.
Guilleminault C, Querra-Salva M, Chowdhuri S, et al: Normal pregnancy, daytime sleeping, snoring and blood pressure. Sleep Med 2000;1:289–297
24.
Franklin KA, Holmgren PA, Jonsson F, et al: Snoring, pregnancy-induced hypertension, and growth retardation of the fetus. Chest 2000;117:137–141.
25.
Pien GW, Fife D, Pack AI, et al: Changes in symptoms of sleep-disordered breathing during pregnancy. Sleep 2005;28:1299–1305.
26.
Mabry RL: Rhinitis of pregnancy. South Med J 1986;79:965–969.
27.
Izci B, Riha RL, Martin SE, et al: The upper airway in pregnancy and pre-eclampsia. Am J Crit Care Med 2003;167:137–140.
28.
Driver HS, Shapiro CM: A longitudinal study of sleep stages in young women during pregnancy and postpartum. Sleep 1992;15:449–453.
29.
Mills GH, Chaffe AG: Sleeping positions adopted by pregnant women of more than 30 weeks gestation. Anaesthesia 1994;49:249–250.
30.
Domingo C, Latorre E, Mirapeix RM, et al: Snoring, obstructive sleep apnea syndrome, and pregnancy. Int J Gynaecol Obstet 2006;93:57–59.
31.
Perez-Chada D, Videla AJ, O’Flaherty ME, et al: Snoring, witnessed sleep apnoeas and pregnancy-induced hypertension. Acta Obstet Gynecol Scand 2007;86:788–792.
32.
Calaora-Tournadre D, Ragot S, Meurice JC, et al: Obstructive sleep apnea syndrome during pregnancy: prevalence of main symptoms and relationship with pregnancy induced-hypertension and intra-uterine growth retardation. Rev Med Interne 2006;27:291–295.
33.
Guilleminault C, Kreutzer M, Chang JL: Pregnancy, sleep-disordered breathing and treatment with nasal continuous positive airway pressure. Sleep Med 2004;5:43–51.
34.
Lopes EA, Coin de Carvalho LB, Da Costa Seguro PB, et al: Sleep disorders in pregnancy. Arq Neuropsiquiatr 2004;62:217–221.
35.
Majewska MD, Harrison NL, Schwartz RD, et al: Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 1986;232:1004–1007.
36.
Ekbom KA: Restless legs syndrome. Acta Med Scand 1945;158(suppl):4–122.
37.
Goodman JDS, Brodie C, Ayida GA: Restless leg syndrome in pregnancy. BMJ 1988;297:1101–1102.
38.
Suzuki K, Ohida T, Sone T, et al: The prevalence of restless legs syndrome among pregnant women in Japan and relationship between restless legs syndrome and sleep problems. Sleep 2003;26:673–677.
39.
Manconi M, Govoni V, De Vito A, et al: Pregnancy as a risk factor for restless legs syndrome. Sleep Med 2004;5:305–308.
40.
Lee KA, Zaffke ME, Baratte-Beebe K: Restless legs syndrome and sleep disturbance during pregnancy: the role of folate and iron. J Womens Health Gen Med 2001;10:335–341.
41.
Allen RP, Picchietti D, Hening WA, et al: Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2002;4:101–119.
42.
Nikkola E, Ekblad U, Ekholm E, et al: Sleep in multiple pregnancy. Breathing patterns, oxygenation, and periodic leg movements. Am J Obstet Gynecol 1996;174:1622–1625.
43.
Heman C, Pohjasvaara T, Tolonen U, et al: Parasomnias decline during pregnancy. Acta Neurol Scand 2002;105:209–214.
© 2009 S. Karger AG, Basel
2009
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.